SCICOTEC GMBH
Patent Owner
Stats
- 3 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Dec 21, 2017 most recent publication
Details
- 3 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 524 Total Citation Count
- Sep 30, 2001 Earliest Filing
- 4 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9242069 Method for control of stem cell injection into the bodyFeb 28, 05Jan 26, 16[A61K, C12N, A61M]
7452532 Transluminal application of adult stem cells for body organ tissue repairSep 30, 04Nov 18, 08[C12N]
6805860 Method of transluminal application of myogenic cells for repair or replacement of heart tissueSep 30, 01Oct 19, 04[A01N, A61M]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0039,460 Transluminal delivery of regenerative cells to body tissueAbandonedMay 13, 13Feb 06, 14[A61M]
2009/0155,175 SIMULTANEOUS TRANSLUMINAL CORONARY SINUS APPLICATION OF CELLS IN CONJUNCTION WITH DEVICE RESYNCHRONIZATION THERAPYAbandonedNov 18, 08Jun 18, 09[A61K, A61N, A61M]
2004/0228,800 Non-invasive identification of patients at increased risk for myocardial infarctionAbandonedMay 15, 03Nov 18, 04[A61K]
2004/0048,375 Application of pluripotential stem cells for body organ tissue repair and venous capillary expansionAbandonedMar 11, 03Mar 11, 04[C12N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.